GNC Holdings (NYSE:GNC) signs an agreement regarding a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group ("Hayao"), a leading pharmaceutical company in China. Under the terms of the agreement, Hayao will invest ~$300M in GNC in the form of newly issued convertible perpetual preferred shares with a conversion...